Latest Breaking News On - மார்த்தா பிகுேய்ரேதோ - Page 3 : comparemela.com

Notas positivas para o novo plano de desconfinamento a conta-gotas

Notas positivas para o novo plano de desconfinamento a conta-gotas
jornaldocentro.pt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jornaldocentro.pt Daily Mail and Mail on Sunday newspapers.

Marta figueiredoPrime ministerMeghan coastAlready warIsabel pearமார்த்தா பிகுேய்ரேதோப்ரைம் அமைச்சர்

National MS Society Partnership Targets Autoimmune Disease Research

National MS Society Partnership Targets Autoimmune Disease Research
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Marta figueiredoTeodora staevaMark allegrettaSanjoy duttaLupus research allianceUniversity of lisbonNational ms societyNational multiple sclerosis societyBiomedical sciencesImmune mediated diseasesNovel approachesTherapeutic insightsLupus researchDevelopmental biologyUniversidade de lisboaமார்த்தா பிகுேய்ரேதோ

Imcyse Raises €21 3M for Therapies in MS, Other Autoimmune Diseases

5 (3) Imcyse has raised €21.3 million ($25.8 million) in funding to advance its innovative immunotherapy platform for the treatment of multiple sclerosis (MS) and other severe autoimmune diseases. The funding was a result of a series B financing round featuring existing investors such as Biogenosis, Société Fédérale de Participations et d’Investissement, and the Catholic University of Leuven, as well as the newest investor Pfizer, which took an equity stake as part of a previously announced licensing agreement. “Completing this financing round reinforces the strength of the Company, allowing us to advance our programs to the next phase of development,” Denis Bedoret, PhD, Imcyse’s CEO, said in a press release.

Marta figueiredoDenis bedoretUniversity of lisbonBiomedical sciencesCatholic university of leuvenCatholic universityDevelopmental biologyUniversidade de lisboaமார்த்தா பிகுேய்ரேதோபல்கலைக்கழகம் ஆஃப் லிஸ்பன்உயிர் மருத்துவ அறிவியல்கத்தோலிக் பல்கலைக்கழகம்வளர்ச்சி உயிரியல்யுனிவர்சிடேட் டி லிஸ்போவா

AI-powered Robotic Glove May Help Improve Hand Grip for MS Patients

4.1 (14) BioLiberty, a Scottish biotech startup, has developed a robotic glove that uses artificial intelligence (AI) to improve the hand grip in people with muscle weakness due to multiple sclerosis (MS) and other conditions. The technology may be closer to entering people’s homes now that the startup has secured support from the Edinburgh Business School’s Incubator, based at Heriot-Watt University, in Scotland. “Up to now, we’ve funded the company from business competition awards so being accepted into the Edinburgh Business School Incubator program is a huge boost,” Ross O’Hanlon, one of the four engineering graduates who founded BioLiberty, said in a press release.

United kingdomCity ofMarta figueiredoRoss ohanlonEdinburgh business school incubatorUniversity of lisbonGlobal research innovationLeiden university medical centerWatt universityBiomedical sciencesEdinburgh business schoolHeriot watt universityDevelopmental biologyMedical microbiologyInfectious diseasesApplied biology

MS-linked Molecule IL-17 Impaired Immune Cells in Mice s Brains

Sustained, excessive levels of IL-17, a pro-inflammatory molecule linked to autoimmune diseases such as multiple sclerosis, are focus of mouse study.

Marta figueiredoTetsuya sasakiUniversity of lisbonLeiden university medical centerBiomedical sciencesUniversity of tsukubaDevelopmental biologyMedical microbiologyInfectious diseasesApplied biologyInstituto de medicina molecularமார்த்தா பிகுேய்ரேதோபல்கலைக்கழகம் ஆஃப் லிஸ்பன்உயிர் மருத்துவ அறிவியல்பல்கலைக்கழகம் ஆஃப் ட்சூகுபாவளர்ச்சி உயிரியல்